Chicago-based Artisight secures $42M in a series B round funding. The investment included full participation from Series A investors, including chipmaker NVIDIA (NVDA), as well as a number of new strategic and client health system investors.
The corporation plans to hire twice as many people with the money. Under the direction of CEO Andrew Gostine, MD, MBA, Artisight offers a platform that streamlines safe patient care, including virtual nursing, by fusing IoT sensors with deep learning and open integration standards.
Read also – KY-based CSI Secures a Strategic Investment
Computer vision, speech recognition, vital sign monitoring, indoor positioning, and actionable analytics reporting are among its HIPAA-compliant features.
By utilising these integrated capabilities, physicians may better promote improved patient outcomes and satisfaction, decrease administrative costs, and spend more time directly caring for patients. They also minimise the load of documentation and coordination.
Read also – PA-based MedRisk Acquired Medata
About Artisight
Artisight is a healthcare technology innovator that is revolutionising the sector with its software solutions for ambient artificial intelligence. Their platform, which is independent of hardware, gathers and evaluates data from several sources to produce high-quality, structured data that streamlines workflows and facilitates automation in healthcare settings.
Read also – CA-based Rainbow Secures $12M in Seed Funding
